Richard Ahrens, MD
Affiliations: | Pediatrics | University of Iowa, Iowa City, IA |
Area:
aerosol deliveryGoogle:
"Richard Ahrens"Bio:
Fellowship 1977-1980; faculty at University of Iowa 1980-
Parents
Sign in to add mentor| Miles Weinberger | fellowship/program director | 1977-1980 | University of Iowa |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Allan R, Haughie S, Ahrens R, et al. (2019) A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery |
| Konstan MW, Plant BJ, Elborn JS, et al. (2015) Efficacy response in CF patients treated with ivacaftor: post-hoc analysis. Pediatric Pulmonology. 50: 447-55 |
| Mondal P, Kandala B, Ahrens R, et al. (2014) Nonprescription racemic epinephrine for asthma. The Journal of Allergy and Clinical Immunology. in Practice. 2: 575-8 |
| Prabhakaran S, Shuster J, Ahrens R, et al. (2011) Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β₂-adrenergic agonist. Pharmacotherapy. 31: 449-57 |
| Konstan MW, Liou TG, Strausbaugh SD, et al. (2010) Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis. Gastroenterology Research and Practice. 2010: 898193 |
| Gibson RL, Retsch-Bogart GZ, Oermann C, et al. (2006) Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis. Pediatric Pulmonology. 41: 656-65 |
| Hendeles L, Marshik PL, Ahrens R, et al. (2005) Response to nonprescription epinephrine inhaler during nocturnal asthma. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 95: 530-4 |
| Moss RB, Mayer-Hamblett N, Wagener J, et al. (2005) Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Pediatric Pulmonology. 39: 209-18 |
| Hendeles L, Beaty R, Ahrens R, et al. (2004) Response to inhaled albuterol during nocturnal asthma. The Journal of Allergy and Clinical Immunology. 113: 1058-62 |
| Geoffroy P, Lalonde RL, Ahrens R, et al. (1999) Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 82: 377-82 |